Publications by authors named "David Moller"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

738

Total Likes

67

Extended Reach

53,085

Social Features

13
P
Pulmonary sarcoidosis: differences in lung function change over time.
Michelle Sharp, Kevin J Psoter, Ali M Mustafa, Edward S Chen, Nancy W Lin, David R Moller

Thorax· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune mechanisms of granuloma formation in sarcoidosis and tuberculosis.
Praveen Weeratunga, David R Moller, Ling-Pei Ho

J Clin Invest· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examination of eQTL Polymorphisms Associated with Increased Risk of Progressive Complicated Sarcoidosis in European and African Descent Subjects.
Nancy G Casanova, Sara M Camp, Manuel L Gonzalez-Garay, Ken Batai, Lori Garman, David R Moller

Eur J Respir Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of PXL065 - deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1).
Stephen A Harrison, Carole Thang, Sébastien Bolze, Sheila Dewitt, Sophie Hallakou-Bozec, David E Moller

J Hepatol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease.
Pascale Gluais Dagorn, Bjoern Buchholz, Andre Kraus, Battsetseg Batchuluun, Hester Bange, David E Moller

Kidney Int· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of Lung Function Phenotypes in Sarcoidosis: Role of Race and Sex Differences.
Michelle Sharp, Kevin J Psoter, Aparna Balasubramanian, Anuhya V Pulapaka, Edward S Chen, David R Moller

Ann Am Thorac Soc· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune mechanisms in fibrotic pulmonary sarcoidosis.
Praveen Weeratunga, David R Moller, Ling-Pei Ho

Eur Respir Rev· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beneficial Effects of the Direct AMP-Kinase Activator PXL770 in In Vitro and In Vivo Models of X-Linked Adrenoleukodystrophy.
Pierre-Axel Monternier, Parveen Parasar, Pierre Theurey, Pascale Gluais Dagorn, Navtej Kaur, David E Moller

J Pharmacol Exp Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic potential of deuterium-stabilized (R)-pioglitazone-PXL065-for X-linked adrenoleukodystrophy.
Pierre-Axel Monternier, Jaspreet Singh, Parveen Parasar, Pierre Theurey, Sheila DeWitt, David E Moller

J Inherit Metab Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced lactic acidosis risk with Imeglimin: Comparison with Metformin.
Pierre Theurey, Guillaume Vial, Eric Fontaine, Pierre-Axel Monternier, Pascale Fouqueray, David E Moller

Physiol Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis.
Pascale Gluais-Dagorn, Marc Foretz, Gregory R Steinberg, Battsetseg Batchuluun, Anna Zawistowska-Deniziak, David E Moller

Hepatol Commun· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomics of bronchoalveolar lavage cells identifies new molecular endotypes of sarcoidosis.
Milica Vukmirovic, Xiting Yan, Kevin F Gibson, Mridu Gulati, Jonas C Schupp, David R Moller

Eur Respir J· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic effects of direct AMP kinase activation in humans with insulin resistance and non-alcoholic fatty liver disease: A phase 1b study.
Pascale Fouqueray, Sebastien Bolze, Julie Dubourg, Sophie Hallakou-Bozec, Pierre Theurey, David E Moller

Cell Rep Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a study.
Kenneth Cusi, Naim Alkhouri, Stephen A Harrison, Pascale Fouqueray, David E Moller

Lancet Gastroenterol Hepatol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational prioritization strategy allows the design of macrolide derivatives that overcome antibiotic resistance.
Gerhard König, Pandian Sokkar, Niclas Pryk, Sascha Heinrich, David Möller

Proc Natl Acad Sci U S A· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action.
Sophie Hallakou-Bozec, Micheline Kergoat, Pascale Fouqueray, Sébastien Bolze, David E Moller

PLoS One· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PLF+PS or ALIF+PS: which has a lower operative nonunion rate? Analysis of a cohort of 2,061 patients from a National Spine Registry.
Elizabeth P Norheim, Kathryn E Royse, Harsimran S Brara, David J Moller, Patrick W Suen

Spine J· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imeglimin preserves islet β-cell mass in Type 2 diabetic ZDF rats.
Sophie Hallakou-Bozec, Micheline Kergoat, David E Moller, Sébastien Bolze

Endocrinol Diabetes Metab· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Operative Nonunion Rates in Posterolateral Lumbar Fusions: Analysis of a Cohort of 2591 Patients from a National Spine Registry.
Kern H Guppy, Kathryn E Royse, Elizabeth P Norheim, David J Moller, Patrick W Suen

World Neurosurg· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Medication Adherence and Clinical Outcomes in Sarcoidosis.
Michelle Sharp, Taylor Brown, Edward S Chen, Cynthia S Rand, David R Moller

Chest· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and MRI phenotypes of sarcoidosis-associated myelopathy.
Olwen C Murphy, Andrea Salazar-Camelo, Jorge A Jimenez, Paula Barreras, Maria I Reyes, David R Moller

Neurol Neuroimmunol Neuroinflamm· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A data workflow to support plant breeding decisions from a terrestrial field-based high-throughput plant phenotyping system.
Alison L Thompson, Kelly R Thorp, Matthew M Conley, Michael Roybal, David Moller

Plant Methods· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychological burden associated with worse clinical outcomes in sarcoidosis.
Michelle Sharp, Taylor Brown, Edward Chen, Cynthia S Rand, David R Moller

BMJ Open Respir Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discrepant Advanced Directives and Code Status Orders: A Preventable Medical Error.
Barry Meisenberg, Sohail Zaidi, Lori Franks, David Moller, David Mooradian

J Hosp Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis